FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386323562> ?p ?o ?g. }

• W4386323562 abstract "Abstract Background: Pneumocystis jirovecii pneumonia (PJP) is a life-threatening and severe disease in immunocompromised hosts. The synergic regimen based on sulfamethoxazole-trimethoprim (SMX-TMP) combination of caspofungin and glucocorticosteroid (GCS) may be a potential first-line therapy. Therefore, it is important to explore the efficacy and safety of this synergic therapy to treat non-HIV PJP patient. Methods: We retrospectively analyzed the data of 38 patients with non-HIV PJP at the the First Affiliated Hospital of Xi’an Jiaotong University. Patients were divided into two groups: synergic therapy group (ST group, n=20) and monotherapy group (MT group, n=18). All patients were from ICU and defined as severe PJP. In ST group, all patients were treated by SMX-TMP (TMP 15-20 mg/kg per day) combined with caspofungin (70 mg as loading dose then 50 mg/day as maintenance dose) and GCS (methylprednisolone 40-80 mg/day). Patients in MT group were only treated by TMP-SMX (TMP 15-20 mg/kg per day). The clinical response, adverse events and mortality were compared between these two groups. Results: The positive clinical response in ST group was significant higher than that in MT group, which was 100.00% vs 66.70% (P=0.005). The incidence of adverse events in MT group was higher than that in ST group, which was 50.00% vs 15.00% (P=0.022). Furthermore, the dose of TMP and duration of fever in ST group were remarkably lower than that in MT group, which were 15.71 mg/kg/day vs 18.35 mg/kg/day (P=0.001) and 7.00 days vs 11.50 days (P=0.029), respectively. However, there was no significant differences in all-cause mortality and duration of hospital stay between MT group and ST group. Conclusions: In comparison with SMZ/TMP monotherapy, the synergic therapy (SMZ-TMP combination of caspofungin and GCS) to treatment non-HIV PJP can increase the positive clinical response rate and decrease the incidence of adverse events and shorten the duration of fever. These results indicated that the synergic therapy was efficacy and safety to treatment severe non-HIV PJP." @default.
• W4386323562 created "2023-09-01" @default.
• W4386323562 creator A5001591660 @default.
• W4386323562 creator A5013520103 @default.
• W4386323562 creator A5019560977 @default.
• W4386323562 creator A5032528000 @default.
• W4386323562 creator A5050830339 @default.
• W4386323562 creator A5056571523 @default.
• W4386323562 creator A5057979711 @default.
• W4386323562 creator A5058794904 @default.
• W4386323562 creator A5074507334 @default.
• W4386323562 creator A5082313170 @default.
• W4386323562 creator A5084197958 @default.
• W4386323562 creator A5084434322 @default.
• W4386323562 date "2023-08-31" @default.
• W4386323562 modified "2023-09-27" @default.
• W4386323562 title "The regimen based on trimethoprim/sulfamethoxazole combination of caspofungin and corticosteroids as the first-line therapy for non-HIV patients with severe pneumocystis jirovecii pneumonia：a retrospective research of a tertiary hospital" @default.
• W4386323562 cites W1606020204 @default.
• W4386323562 cites W1825501986 @default.
• W4386323562 cites W1913496425 @default.
• W4386323562 cites W1978209921 @default.
• W4386323562 cites W1987092284 @default.
• W4386323562 cites W2009276775 @default.
• W4386323562 cites W2043572962 @default.
• W4386323562 cites W2086489545 @default.
• W4386323562 cites W2114359819 @default.
• W4386323562 cites W2139422569 @default.
• W4386323562 cites W2170896054 @default.
• W4386323562 cites W2186096181 @default.
• W4386323562 cites W2250182074 @default.
• W4386323562 cites W2351199759 @default.
• W4386323562 cites W2607650379 @default.
• W4386323562 cites W2991018517 @default.
• W4386323562 cites W3033198010 @default.
• W4386323562 cites W3047524868 @default.
• W4386323562 cites W3083953452 @default.
• W4386323562 doi "https://doi.org/10.21203/rs.3.rs-3150725/v1" @default.
• W4386323562 hasPublicationYear "2023" @default.
• W4386323562 type Work @default.
• W4386323562 citedByCount "0" @default.
• W4386323562 crossrefType "posted-content" @default.
• W4386323562 hasAuthorship W4386323562A5001591660 @default.
• W4386323562 hasAuthorship W4386323562A5013520103 @default.
• W4386323562 hasAuthorship W4386323562A5019560977 @default.
• W4386323562 hasAuthorship W4386323562A5032528000 @default.
• W4386323562 hasAuthorship W4386323562A5050830339 @default.
• W4386323562 hasAuthorship W4386323562A5056571523 @default.
• W4386323562 hasAuthorship W4386323562A5057979711 @default.
• W4386323562 hasAuthorship W4386323562A5058794904 @default.
• W4386323562 hasAuthorship W4386323562A5074507334 @default.
• W4386323562 hasAuthorship W4386323562A5082313170 @default.
• W4386323562 hasAuthorship W4386323562A5084197958 @default.
• W4386323562 hasAuthorship W4386323562A5084434322 @default.
• W4386323562 hasBestOaLocation W43863235621 @default.
• W4386323562 hasConcept C120665830 @default.
• W4386323562 hasConcept C121332964 @default.
• W4386323562 hasConcept C126322002 @default.
• W4386323562 hasConcept C141071460 @default.
• W4386323562 hasConcept C16005928 @default.
• W4386323562 hasConcept C167135981 @default.
• W4386323562 hasConcept C197934379 @default.
• W4386323562 hasConcept C2777914695 @default.
• W4386323562 hasConcept C2779425571 @default.
• W4386323562 hasConcept C2779548794 @default.
• W4386323562 hasConcept C2779629538 @default.
• W4386323562 hasConcept C2780372218 @default.
• W4386323562 hasConcept C2780402444 @default.
• W4386323562 hasConcept C2780728791 @default.
• W4386323562 hasConcept C2781413609 @default.
• W4386323562 hasConcept C501593827 @default.
• W4386323562 hasConcept C61511704 @default.
• W4386323562 hasConcept C71924100 @default.
• W4386323562 hasConcept C86803240 @default.
• W4386323562 hasConcept C89423630 @default.
• W4386323562 hasConcept C90924648 @default.
• W4386323562 hasConceptScore W4386323562C120665830 @default.
• W4386323562 hasConceptScore W4386323562C121332964 @default.
• W4386323562 hasConceptScore W4386323562C126322002 @default.
• W4386323562 hasConceptScore W4386323562C141071460 @default.
• W4386323562 hasConceptScore W4386323562C16005928 @default.
• W4386323562 hasConceptScore W4386323562C167135981 @default.
• W4386323562 hasConceptScore W4386323562C197934379 @default.
• W4386323562 hasConceptScore W4386323562C2777914695 @default.
• W4386323562 hasConceptScore W4386323562C2779425571 @default.
• W4386323562 hasConceptScore W4386323562C2779548794 @default.
• W4386323562 hasConceptScore W4386323562C2779629538 @default.
• W4386323562 hasConceptScore W4386323562C2780372218 @default.
• W4386323562 hasConceptScore W4386323562C2780402444 @default.
• W4386323562 hasConceptScore W4386323562C2780728791 @default.
• W4386323562 hasConceptScore W4386323562C2781413609 @default.
• W4386323562 hasConceptScore W4386323562C501593827 @default.
• W4386323562 hasConceptScore W4386323562C61511704 @default.
• W4386323562 hasConceptScore W4386323562C71924100 @default.
• W4386323562 hasConceptScore W4386323562C86803240 @default.
• W4386323562 hasConceptScore W4386323562C89423630 @default.
• W4386323562 hasConceptScore W4386323562C90924648 @default.
• W4386323562 hasLocation W43863235621 @default.
• W4386323562 hasOpenAccess W4386323562 @default.
• W4386323562 hasPrimaryLocation W43863235621 @default.
• W4386323562 hasRelatedWork W1829813424 @default.

• next